| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -40 @ USD 117.94 | USD -4,718 | The ETF sold 40 shares of DVA on 2025-12-16. The shares were previously bought for an average price of USD 141.04. The DaVita HealthCare Partners Inc shares were sold for -16.4% lower than average price of previous purchases. This resulted in an overall loss of USD 924 The average price that the ETF previously sold DVA share for is USD 141.789 which is higher than the selling price of USD 117.94 on 2025-12-16. |
| HSIC - Henry Schein Inc | SELL | -116 @ USD 77.05 | USD -8,938 | The ETF sold 116 shares of HSIC on 2025-12-16. The shares were previously bought for an average price of USD 71.8543. The Henry Schein Inc shares were sold for 7.2% higher than average price of previous purchases. This sale made a profit of USD 603 The average price that the ETF previously sold HSIC share for is USD 69.9038 so the ETF has sold 116 shares on 2025-12-16 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -60 @ USD 160.88 | USD -9,653 | The ETF sold 60 shares of MOH on 2025-12-16. The shares were previously bought for an average price of USD 242.32. The MOH shares were sold for -33.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,886 The average price that the ETF previously sold MOH share for is USD 282.048 which is higher than the selling price of USD 160.88 on 2025-12-16. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 160.88 | USD -9,653 | The ETF sold 60 shares of MOH on 2025-12-16. The shares were previously bought for an average price of USD 242.32. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -33.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,886 The average price that the ETF previously sold MOH share for is USD 282.048 which is higher than the selling price of USD 160.88 on 2025-12-16. |
| TECH - Bio-Techne Corp | SELL | -174 @ USD 57.44 | USD -9,995 | The ETF sold 174 shares of TECH on 2025-12-16. The shares were previously bought for an average price of USD 61.9643. The Bio-Techne Corp shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 787 The average price that the ETF previously sold TECH share for is USD 64.8691 which is higher than the selling price of USD 57.44 on 2025-12-16. |
| CRL - Creightons Plc | SELL | -54 @ USD 195.22 | USD -10,542 | The ETF sold 54 shares of CRL on 2025-12-16. The shares were previously bought for an average price of USD 170.985. The Creightons Plc shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of USD 1,309 The average price that the ETF previously sold CRL share for is USD 173.82 so the ETF has sold 54 shares on 2025-12-16 at a higher price than the previous selling average. |
| BAX - Baxter International Inc | SELL | -576 @ USD 19.05 | USD -10,973 | The ETF sold 576 shares of BAX on 2025-12-16. The shares were previously bought for an average price of USD 27.411. The Baxter International Inc shares were sold for -30.5% lower than average price of previous purchases. This resulted in an overall loss of USD 4,816 The average price that the ETF previously sold BAX share for is USD 30.3764 which is higher than the selling price of USD 19.05 on 2025-12-16. |
| MRNA - Moderna Inc | SELL | -384 @ USD 29.89 | USD -11,478 | The ETF sold 384 shares of MRNA on 2025-12-16. The shares were previously bought for an average price of USD 30.9938. The Moderna Inc shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of USD 424 The average price that the ETF previously sold MRNA share for is USD 36.2109 which is higher than the selling price of USD 29.89 on 2025-12-16. |
| ALGN - Align Technology Inc | SELL | -74 @ USD 162.89 | USD -12,054 | The ETF sold 74 shares of ALGN on 2025-12-16. The shares were previously bought for an average price of USD 170.491. The Align Technology Inc shares were sold for -4.5% lower than average price of previous purchases. This resulted in an overall loss of USD 562 The average price that the ETF previously sold ALGN share for is USD 196.877 which is higher than the selling price of USD 162.89 on 2025-12-16. |
| RVTY - Revvity Inc. | SELL | -132 @ USD 96.27 | USD -12,708 | The ETF sold 132 shares of RVTY on 2025-12-16. The shares were previously bought for an average price of USD 104.535. The Revvity Inc. shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,091 The average price that the ETF previously sold RVTY share for is USD 106.392 which is higher than the selling price of USD 96.27 on 2025-12-16. |
| SOLV - Solventum Corp. | SELL | -164 @ USD 80.59 | USD -13,217 | The ETF sold 164 shares of SOLV on 2025-12-16. The shares were previously bought for an average price of USD 74.9945. The Solventum Corp. shares were sold for 7.5% higher than average price of previous purchases. This sale made a profit of USD 918 The average price that the ETF previously sold SOLV share for is USD 73.066 so the ETF has sold 164 shares on 2025-12-16 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 222.64 | USD -13,804 | The ETF sold 62 shares of UHS on 2025-12-16. The shares were previously bought for an average price of USD 200.832. The Universal Health Services Inc shares were sold for 10.9% higher than average price of previous purchases. This sale made a profit of USD 1,352 The average price that the ETF previously sold UHS share for is USD 196.935 so the ETF has sold 62 shares on 2025-12-16 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -1,290 @ USD 11.46 | USD -14,783 | The ETF sold 1290 shares of VTRS on 2025-12-16. The shares were previously bought for an average price of USD 10.4055. The Viatris Inc shares were sold for 10.1% higher than average price of previous purchases. This sale made a profit of USD 1,360 The average price that the ETF previously sold VTRS share for is USD 10.9566 so the ETF has sold 1290 shares on 2025-12-16 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -184 @ USD 97.03 | USD -17,854 | The ETF sold 184 shares of INCY on 2025-12-16. The shares were previously bought for an average price of USD 80.4404. The Incyte Corporation shares were sold for 20.6% higher than average price of previous purchases. This sale made a profit of USD 3,052 The average price that the ETF previously sold INCY share for is USD 76.4253 so the ETF has sold 184 shares on 2025-12-16 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -224 @ USD 81.04 | USD -18,153 | The ETF sold 224 shares of COO on 2025-12-16. The shares were previously bought for an average price of USD 81.8045. The The Cooper Companies, Inc. Common Stock shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 171 The average price that the ETF previously sold COO share for is USD 88.1692 which is higher than the selling price of USD 81.04 on 2025-12-16. |
| HOLX - Hologic Inc | SELL | -248 @ USD 75.02 | USD -18,605 | The ETF sold 248 shares of HOLX on 2025-12-16. The shares were previously bought for an average price of USD 68.9992. The Hologic Inc shares were sold for 8.7% higher than average price of previous purchases. This sale made a profit of USD 1,493 The average price that the ETF previously sold HOLX share for is USD 70.8971 so the ETF has sold 248 shares on 2025-12-16 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -222 @ USD 90.91 | USD -20,182 | The ETF sold 222 shares of ZBH on 2025-12-16. The shares were previously bought for an average price of USD 100.939. The Zimmer Biomet Holdings Inc shares were sold for -9.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,226 The average price that the ETF previously sold ZBH share for is USD 103.222 which is higher than the selling price of USD 90.91 on 2025-12-16. |
| CNC - Concurrent Technologies Plc | SELL | -522 @ USD 38.97 | USD -20,342 | The ETF sold 522 shares of CNC on 2025-12-16. The shares were previously bought for an average price of USD 49.5907. The Concurrent Technologies Plc shares were sold for -21.4% lower than average price of previous purchases. This resulted in an overall loss of USD 5,544 The average price that the ETF previously sold CNC share for is USD 50.4176 which is higher than the selling price of USD 38.97 on 2025-12-16. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 266.44 | USD -20,782 | The ETF sold 78 shares of WST on 2025-12-16. The shares were previously bought for an average price of USD 262.16. The West Pharmaceutical Services Inc shares were sold for 1.6% higher than average price of previous purchases. This sale made a profit of USD 334 The average price that the ETF previously sold WST share for is USD 278.355 which is higher than the selling price of USD 266.44 on 2025-12-16. |
| DGX - Quest Diagnostics Incorporated | SELL | -124 @ USD 178.66 | USD -22,154 | The ETF sold 124 shares of DGX on 2025-12-16. The shares were previously bought for an average price of USD 174.759. The Quest Diagnostics Incorporated shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 484 The average price that the ETF previously sold DGX share for is USD 168.163 so the ETF has sold 124 shares on 2025-12-16 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -78 @ USD 288.73 | USD -22,521 | The ETF sold 78 shares of PODD on 2025-12-16. The shares were previously bought for an average price of USD 291.998. The Insulet Corporation shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 255 The average price that the ETF previously sold PODD share for is USD 280.777 so the ETF has sold 78 shares on 2025-12-16 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -92 @ USD 258.11 | USD -23,746 | The ETF sold 92 shares of LH on 2025-12-16. The shares were previously bought for an average price of USD 255.61. The Laboratory Corporation of America Holdings shares were sold for 1.0% higher than average price of previous purchases. This sale made a profit of USD 230 The average price that the ETF previously sold LH share for is USD 246.062 so the ETF has sold 92 shares on 2025-12-16 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -66 @ USD 378.53 | USD -24,983 | The ETF sold 66 shares of WAT on 2025-12-16. The shares were previously bought for an average price of USD 363.018. The Waters Corporation shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 1,024 The average price that the ETF previously sold WAT share for is USD 364.82 so the ETF has sold 66 shares on 2025-12-16 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -66 @ USD 378.53 | USD -24,983 | The ETF sold 66 shares of WAT on 2025-12-16. The shares were previously bought for an average price of USD 363.018. The MULETFWATIMETFP shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 1,024 The average price that the ETF previously sold WAT share for is USD 364.82 so the ETF has sold 66 shares on 2025-12-16 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -108 @ USD 253.03 | USD -27,327 | The ETF sold 108 shares of STE on 2025-12-16. The shares were previously bought for an average price of USD 235.502. The STERIS plc shares were sold for 7.4% higher than average price of previous purchases. This sale made a profit of USD 1,893 The average price that the ETF previously sold STE share for is USD 227.973 so the ETF has sold 108 shares on 2025-12-16 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -162 @ USD 171.5 | USD -27,783 | The ETF sold 162 shares of BIIB on 2025-12-16. The shares were previously bought for an average price of USD 149.86. The Biogen Inc shares were sold for 14.4% higher than average price of previous purchases. This sale made a profit of USD 3,506 The average price that the ETF previously sold BIIB share for is USD 153.581 so the ETF has sold 162 shares on 2025-12-16 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -438 @ USD 66.37 | USD -29,070 | The ETF sold 438 shares of DXCM on 2025-12-16. The shares were previously bought for an average price of USD 72.5831. The DexCom Inc shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,721 The average price that the ETF previously sold DXCM share for is USD 75.4455 which is higher than the selling price of USD 66.37 on 2025-12-16. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 1386.45 | USD -30,502 | The ETF sold 22 shares of MTD on 2025-12-16. The shares were previously bought for an average price of USD 1302.93. The Mettler-Toledo International Inc shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 1,837 The average price that the ETF previously sold MTD share for is USD 1257.4 so the ETF has sold 22 shares on 2025-12-16 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 1386.45 | USD -30,502 | The ETF sold 22 shares of MTD on 2025-12-16. The shares were previously bought for an average price of USD 1302.93. The AMUNDI EUR GOV 710 shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 1,837 The average price that the ETF previously sold MTD share for is USD 1257.4 so the ETF has sold 22 shares on 2025-12-16 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -132 @ USD 258.16 | USD -34,077 | The ETF sold 132 shares of HUM on 2025-12-16. The shares were previously bought for an average price of USD 263.759. The Hummingbird Resources PLC shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 739 The average price that the ETF previously sold HUM share for is USD 268.501 which is higher than the selling price of USD 258.16 on 2025-12-16. |
| HUM - Humana Inc | SELL | -132 @ USD 258.16 | USD -34,077 | The ETF sold 132 shares of HUM on 2025-12-16. The shares were previously bought for an average price of USD 263.759. The Humana Inc shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 739 The average price that the ETF previously sold HUM share for is USD 268.501 which is higher than the selling price of USD 258.16 on 2025-12-16. |
| RMD - ResMed Inc | SELL | -162 @ USD 247.34 | USD -40,069 | The ETF sold 162 shares of RMD on 2025-12-16. The shares were previously bought for an average price of USD 247.356. The ResMed Inc shares were sold for 0.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3 The average price that the ETF previously sold RMD share for is USD 247.273 so the ETF has sold 162 shares on 2025-12-16 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -506 @ USD 82.25 | USD -41,619 | The ETF sold 506 shares of GEHC on 2025-12-16. The shares were previously bought for an average price of USD 80.4102. The GE HealthCare Technologies Inc. shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 931 The average price that the ETF previously sold GEHC share for is USD 79.3453 so the ETF has sold 506 shares on 2025-12-16 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -188 @ USD 221.68 | USD -41,676 | The ETF sold 188 shares of IQV on 2025-12-16. The shares were previously bought for an average price of USD 197.068. The IQVIA Holdings Inc shares were sold for 12.5% higher than average price of previous purchases. This sale made a profit of USD 4,627 The average price that the ETF previously sold IQV share for is USD 191.037 so the ETF has sold 188 shares on 2025-12-16 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -314 @ USD 139.19 | USD -43,706 | The ETF sold 314 shares of A on 2025-12-16. The shares were previously bought for an average price of USD 133.974. The Agilent Technologies Inc shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 1,638 The average price that the ETF previously sold A share for is USD 131.393 so the ETF has sold 314 shares on 2025-12-16 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -262 @ USD 197.89 | USD -51,847 | The ETF sold 262 shares of CAH on 2025-12-16. The shares were previously bought for an average price of USD 154.731. The Cardinal Health Inc shares were sold for 27.9% higher than average price of previous purchases. This sale made a profit of USD 11,308 The average price that the ETF previously sold CAH share for is USD 143.062 so the ETF has sold 262 shares on 2025-12-16 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -652 @ USD 85.32 | USD -55,629 | The ETF sold 652 shares of EW on 2025-12-16. The shares were previously bought for an average price of USD 75.5478. The Edwards Lifesciences Corp shares were sold for 12.9% higher than average price of previous purchases. This sale made a profit of USD 6,371 The average price that the ETF previously sold EW share for is USD 73.1136 so the ETF has sold 652 shares on 2025-12-16 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -492 @ USD 123.23 | USD -60,629 | The ETF sold 492 shares of ZTS on 2025-12-16. The shares were previously bought for an average price of USD 150.681. The Zoetis Inc shares were sold for -18.2% lower than average price of previous purchases. This resulted in an overall loss of USD 13,506 The average price that the ETF previously sold ZTS share for is USD 163.733 which is higher than the selling price of USD 123.23 on 2025-12-16. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 693.18 | USD -61,000 | The ETF sold 88 shares of IDXX on 2025-12-16. The shares were previously bought for an average price of USD 554.528. The IDEXX Laboratories Inc shares were sold for 25.0% higher than average price of previous purchases. This sale made a profit of USD 12,201 The average price that the ETF previously sold IDXX share for is USD 496.445 so the ETF has sold 88 shares on 2025-12-16 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -316 @ USD 196.39 | USD -62,059 | The ETF sold 316 shares of BDX on 2025-12-16. The shares were previously bought for an average price of USD 206.984. The Becton Dickinson and Company shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,348 The average price that the ETF previously sold BDX share for is USD 206.218 which is higher than the selling price of USD 196.39 on 2025-12-16. |
| COR - Cencora Inc. | SELL | -214 @ USD 341.72 | USD -73,128 | The ETF sold 214 shares of COR on 2025-12-16. The shares were previously bought for an average price of USD 302.431. The Cencora Inc. shares were sold for 13.0% higher than average price of previous purchases. This sale made a profit of USD 8,408 The average price that the ETF previously sold COR share for is USD 275.754 so the ETF has sold 214 shares on 2025-12-16 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -294 @ USD 276.11 | USD -81,176 | The ETF sold 294 shares of CI on 2025-12-16. The shares were previously bought for an average price of USD 298.851. The Cigna Corp shares were sold for -7.6% lower than average price of previous purchases. This resulted in an overall loss of USD 6,686 The average price that the ETF previously sold CI share for is USD 312.882 which is higher than the selling price of USD 276.11 on 2025-12-16. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -112 @ USD 746.36 | USD -83,592 | The ETF sold 112 shares of REGN on 2025-12-16. The shares were previously bought for an average price of USD 674.01. The Regeneron Pharmaceuticals Inc shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 8,103 The average price that the ETF previously sold REGN share for is USD 686.694 so the ETF has sold 112 shares on 2025-12-16 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -180 @ USD 469.79 | USD -84,562 | The ETF sold 180 shares of HCA on 2025-12-16. The shares were previously bought for an average price of USD 393.622. The HCA Holdings Inc shares were sold for 19.4% higher than average price of previous purchases. This sale made a profit of USD 13,710 The average price that the ETF previously sold HCA share for is USD 373.667 so the ETF has sold 180 shares on 2025-12-16 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -248 @ USD 351.9 | USD -87,271 | The ETF sold 248 shares of ELV on 2025-12-16. The shares were previously bought for an average price of USD 373.585. The Elevance Health Inc shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 5,378 The average price that the ETF previously sold ELV share for is USD 387.211 which is higher than the selling price of USD 351.9 on 2025-12-16. |
| ELV - Elevance Health Inc | SELL | -248 @ USD 351.9 | USD -87,271 | The ETF sold 248 shares of ELV on 2025-12-16. The shares were previously bought for an average price of USD 373.585. The Elevance Health Inc shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 5,378 The average price that the ETF previously sold ELV share for is USD 387.211 which is higher than the selling price of USD 351.9 on 2025-12-16. |
| CVS - CVS Health Corp | SELL | -1,398 @ USD 78.29 | USD -109,449 | The ETF sold 1398 shares of CVS on 2025-12-16. The shares were previously bought for an average price of USD 70.1315. The CVS Health Corp shares were sold for 11.6% higher than average price of previous purchases. This sale made a profit of USD 11,406 The average price that the ETF previously sold CVS share for is USD 62.9232 so the ETF has sold 1398 shares on 2025-12-16 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -136 @ USD 809.96 | USD -110,155 | The ETF sold 136 shares of MCK on 2025-12-16. The shares were previously bought for an average price of USD 715.677. The McKesson Corporation shares were sold for 13.2% higher than average price of previous purchases. This sale made a profit of USD 12,822 The average price that the ETF previously sold MCK share for is USD 672.285 so the ETF has sold 136 shares on 2025-12-16 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -2,242 @ USD 54.23 | USD -121,584 | The ETF sold 2242 shares of BMY on 2025-12-16. The shares were previously bought for an average price of USD 52.2633. The Bloomsbury Publishing Plc shares were sold for 3.8% higher than average price of previous purchases. This sale made a profit of USD 4,409 The average price that the ETF previously sold BMY share for is USD 52.9214 so the ETF has sold 2242 shares on 2025-12-16 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -282 @ USD 454.96 | USD -128,299 | The ETF sold 282 shares of VRTX on 2025-12-16. The shares were previously bought for an average price of USD 447.762. The Vertex Pharmaceuticals Inc shares were sold for 1.6% higher than average price of previous purchases. This sale made a profit of USD 2,030 The average price that the ETF previously sold VRTX share for is USD 465.702 which is higher than the selling price of USD 454.96 on 2025-12-16. |
| SYK - Stryker Corporation | SELL | -378 @ USD 351.69 | USD -132,939 | The ETF sold 378 shares of SYK on 2025-12-16. The shares were previously bought for an average price of USD 373.144. The Stryker Corporation shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 8,110 The average price that the ETF previously sold SYK share for is USD 379.076 which is higher than the selling price of USD 351.69 on 2025-12-16. |
| MDT - Medtronic PLC | SELL | -1,412 @ USD 97.72 | USD -137,981 | The ETF sold 1412 shares of MDT on 2025-12-16. The shares were previously bought for an average price of USD 92.1039. The Medtronic PLC shares were sold for 6.1% higher than average price of previous purchases. This sale made a profit of USD 7,930 The average price that the ETF previously sold MDT share for is USD 88.5344 so the ETF has sold 1412 shares on 2025-12-16 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -1,632 @ USD 92.95 | USD -151,694 | The ETF sold 1632 shares of BSX on 2025-12-16. The shares were previously bought for an average price of USD 98.628. The Boston Scientific Corporation shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,266 The average price that the ETF previously sold BSX share for is USD 95.091 which is higher than the selling price of USD 92.95 on 2025-12-16. |
| BSX - MULSTRXSSXIMETFP | SELL | -1,632 @ USD 92.95 | USD -151,694 | The ETF sold 1632 shares of BSX on 2025-12-16. The shares were previously bought for an average price of USD 98.628. The MULSTRXSSXIMETFP shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,266 The average price that the ETF previously sold BSX share for is USD 95.091 which is higher than the selling price of USD 92.95 on 2025-12-16. |
| DHR - Danaher Corporation | SELL | -700 @ USD 224.7 | USD -157,290 | The ETF sold 700 shares of DHR on 2025-12-16. The shares were previously bought for an average price of USD 216.032. The Danaher Corporation shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of USD 6,068 The average price that the ETF previously sold DHR share for is USD 222.488 so the ETF has sold 700 shares on 2025-12-16 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -700 @ USD 224.7 | USD -157,290 | The ETF sold 700 shares of DHR on 2025-12-16. The shares were previously bought for an average price of USD 216.032. The Danaher Corporation shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of USD 6,068 The average price that the ETF previously sold DHR share for is USD 222.488 so the ETF has sold 700 shares on 2025-12-16 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -6,268 @ USD 25.53 | USD -160,022 | The ETF sold 6268 shares of PFE on 2025-12-16. The shares were previously bought for an average price of USD 25.4746. The Pfizer Inc shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of USD 347 The average price that the ETF previously sold PFE share for is USD 25.3688 so the ETF has sold 6268 shares on 2025-12-16 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -1,368 @ USD 118.78 | USD -162,491 | The ETF sold 1368 shares of GILD on 2025-12-16. The shares were previously bought for an average price of USD 110.415. The Guild Esports Plc shares were sold for 7.6% higher than average price of previous purchases. This sale made a profit of USD 11,443 The average price that the ETF previously sold GILD share for is USD 102.551 so the ETF has sold 1368 shares on 2025-12-16 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -592 @ USD 326.74 | USD -193,430 | The ETF sold 592 shares of AMGN on 2025-12-16. The shares were previously bought for an average price of USD 305.175. The Amgen Inc shares were sold for 7.1% higher than average price of previous purchases. This sale made a profit of USD 12,766 The average price that the ETF previously sold AMGN share for is USD 297.857 so the ETF has sold 592 shares on 2025-12-16 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -394 @ USD 554.58 | USD -218,505 | The ETF sold 394 shares of ISRG on 2025-12-16. The shares were previously bought for an average price of USD 527.803. The Intuitive Surgical Inc shares were sold for 5.1% higher than average price of previous purchases. This sale made a profit of USD 10,550 The average price that the ETF previously sold ISRG share for is USD 532.429 so the ETF has sold 394 shares on 2025-12-16 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -414 @ USD 570.16 | USD -236,046 | The ETF sold 414 shares of TMO on 2025-12-16. The shares were previously bought for an average price of USD 528.507. The Time Out Group plc shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of USD 17,244 The average price that the ETF previously sold TMO share for is USD 502.666 so the ETF has sold 414 shares on 2025-12-16 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -1,914 @ USD 126.86 | USD -242,810 | The ETF sold 1914 shares of ABT on 2025-12-16. The shares were previously bought for an average price of USD 128.289. The Abbott Laboratories shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,735 The average price that the ETF previously sold ABT share for is USD 123.467 so the ETF has sold 1914 shares on 2025-12-16 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -2,748 @ USD 98.27 | USD -270,046 | The ETF sold 2748 shares of MRK on 2025-12-16. The shares were previously bought for an average price of USD 91.1587. The Marks Electrical Group PLC shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 19,542 The average price that the ETF previously sold MRK share for is USD 93.4811 so the ETF has sold 2748 shares on 2025-12-16 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -2,748 @ USD 98.27 | USD -270,046 | The ETF sold 2748 shares of MRK on 2025-12-16. The shares were previously bought for an average price of USD 91.1587. The Merck & Company Inc shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 19,542 The average price that the ETF previously sold MRK share for is USD 93.4811 so the ETF has sold 2748 shares on 2025-12-16 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -994 @ USD 334.2 | USD -332,195 | The ETF sold 994 shares of UNH on 2025-12-16. The shares were previously bought for an average price of USD 423.86. The UnitedHealth Group Incorporated shares were sold for -21.2% lower than average price of previous purchases. This resulted in an overall loss of USD 89,122 The average price that the ETF previously sold UNH share for is USD 468.602 which is higher than the selling price of USD 334.2 on 2025-12-16. |
| ABBV - AbbVie Inc | SELL | -1,942 @ USD 223.67 | USD -434,367 | The ETF sold 1942 shares of ABBV on 2025-12-16. The shares were previously bought for an average price of USD 206.821. The AbbVie Inc shares were sold for 8.1% higher than average price of previous purchases. This sale made a profit of USD 32,721 The average price that the ETF previously sold ABBV share for is USD 193.283 so the ETF has sold 1942 shares on 2025-12-16 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -2,646 @ USD 209.3 | USD -553,808 | The ETF sold 2646 shares of JNJ on 2025-12-16. The shares were previously bought for an average price of USD 174.56. The Johnson & Johnson shares were sold for 19.9% higher than average price of previous purchases. This sale made a profit of USD 91,922 The average price that the ETF previously sold JNJ share for is USD 161.491 so the ETF has sold 2646 shares on 2025-12-16 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -874 @ USD 1054.29 | USD -921,449 | The ETF sold 874 shares of LLY on 2025-12-16. The shares were previously bought for an average price of USD 867.577. The Eli Lilly and Company shares were sold for 21.5% higher than average price of previous purchases. This sale made a profit of USD 163,187 The average price that the ETF previously sold LLY share for is USD 818.855 so the ETF has sold 874 shares on 2025-12-16 at a higher price than the previous selling average. |